BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36884115)

  • 1. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients.
    Proppe L; Jagomast T; Beume S; Klapper L; Gitas G; Köster F; Perner S; Rody A; Ribbat-Idel J; Hanker LC
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7155-7164. PubMed ID: 36884115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy.
    Klepsch V; Hermann-Kleiter N; Baier G
    Immunol Lett; 2016 Oct; 178():31-6. PubMed ID: 26992368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy.
    Klepsch V; Pommermayr M; Humer D; Brigo N; Hermann-Kleiter N; Baier G
    Cell Commun Signal; 2020 Jan; 18(1):8. PubMed ID: 31937317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6.
    Klepsch V; Siegmund K; Baier G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance.
    Hermann-Kleiter N; Klepsch V; Wallner S; Siegmund K; Klepsch S; Tuzlak S; Villunger A; Kaminski S; Pfeifhofer-Obermair C; Gruber T; Wolf D; Baier G
    Cell Rep; 2015 Sep; 12(12):2072-85. PubMed ID: 26387951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of nuclear receptor transcription factor NR2F6 in tumor].
    Huang L; Liu J; Zhu Y; Zhou Q; Xiao B; Sun Z; Li L
    Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2595-2602. PubMed ID: 34472280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput screening for compounds to the orphan nuclear receptor NR2F6.
    Smith E; Campbell S; Wilson AN; Shumate J; Baillargeon P; Scampavia L; Kamenecka TM; Spicer TP; Solt LA
    SLAS Discov; 2022 Jun; 27(4):242-248. PubMed ID: 35331960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NR2F6 as a Prognostic Biomarker in HNSCC.
    Klapper L; Ribbat-Idel J; Kuppler P; Paulsen FO; Bruchhage KL; Rades D; Offermann A; Kirfel J; Wollenberg B; Idel C; Perner S
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21.
    Olson WJ; Jakic B; Labi V; Schoeler K; Kind M; Klepsch V; Baier G; Hermann-Kleiter N
    Cell Rep; 2019 Sep; 28(11):2878-2891.e5. PubMed ID: 31509749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
    Klepsch V; Hermann-Kleiter N; Do-Dinh P; Jakic B; Offermann A; Efremova M; Sopper S; Rieder D; Krogsdam A; Gamerith G; Perner S; Tzankov A; Trajanoski Z; Wolf D; Baier G
    Nat Commun; 2018 Apr; 9(1):1538. PubMed ID: 29670099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the orphan nuclear receptor NR2F6 enhances CD8
    Jakic B; Olson WJ; Siegmund K; Klepsch V; Kimpel J; Labi V; Zehn D; Baier G; Hermann-Kleiter N
    Cell Death Dis; 2021 Feb; 12(2):187. PubMed ID: 33589606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.
    Miftah H; Naji O; Ssi SA; Ghouzlani A; Lakhdar A; Badou A
    Front Immunol; 2023; 14():1139268. PubMed ID: 37575237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma.
    Pang JS; Wen DY; He RQ; Chen G; Lin P; Li JH; Zhao YJ; Wu LY; Chen JH; He Y; Qin LT; Chen JB; Li Y; Yang H
    Bioengineered; 2021 Dec; 12(1):4289-4303. PubMed ID: 34304715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.
    Kim H; Feng Y; Murad R; Pozniak J; Pelz C; Chen Y; Dalal B; Sears R; Sergienko E; Jackson M; Ruppin E; Herlyn M; Harris C; Marine JC; Klepsch V; Baier G; Ronai ZA
    Sci Adv; 2023 Jul; 9(27):eadf6621. PubMed ID: 37406115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic analysis reveals that Snail regulates the expression of the nuclear orphan receptor Nuclear Receptor Subfamily 2 Group F Member 6 (Nr2f6) and interleukin 17 (IL-17) to inhibit adipocyte differentiation.
    Peláez-García A; Barderas R; Batlle R; Viñas-Castells R; Bartolomé RA; Torres S; Mendes M; Lopez-Lucendo M; Mazzolini R; Bonilla F; García de Herreros A; Casal JI
    Mol Cell Proteomics; 2015 Feb; 14(2):303-15. PubMed ID: 25505127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and biological effect of NR2F6 in non-small cell lung cancer.
    Yang SL; Guan HQ; Yang HB; Chen Y; Huang XY; Chen L; Shen ZF; Wang LX
    Front Oncol; 2022; 12():940234. PubMed ID: 36119482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis.
    Olson WJ; Jakic B; Labi V; Woelk J; Derudder E; Baier G; Hermann-Kleiter N
    Front Immunol; 2022; 13():845235. PubMed ID: 36052079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome.
    Liu J; Li T; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1206-1213. PubMed ID: 28387912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.